Nasdaq 100 Stocks SEC Filings — March 12, 2026

12-03-2026

Adicet Bio, Inc. reported a net loss of $116.8M for the year ended December 31, 2025, nearly flat at a 0% change from $117.1M in 2024, with total operating expenses declining 4% to $122.1M due to a 19% drop in G&A to $23.0M, while R&D expenses remained flat at 0% or $99.1M. However, interest income fell 46% to $5.8M, cash used in operating activities increased to $95.2M from $92.4M, cash and equivalents dropped to $38.9M from $56.5M, and total assets decreased to $192.4M from $220.2M.

• ·Common shares outstanding increased to 9.6M from 5.2M, driven by public offering of 4.4M shares net $74.8M.
• ·Stock-based compensation expense declined to $14.3M from $22.2M.
• ·Net loss per share improved to ($16.95) from ($21.33) due to higher share count.
• ·Short-term investments stable at ~$119.7M vs $119.8M.

12-03-2026

Acadia Healthcare Company, Inc. (ACHC) appointed Daniel Cancelmi, former Executive Vice President and CFO of Tenet Healthcare Corporation, to its Board of Directors effective March 12, 2026. Director Wade D. Miquelon will retire at the 2026 Annual Meeting following years of service. As of December 31, 2025, Acadia operates 277 behavioral healthcare facilities with over 12,500 beds, approximately 25,000 employees serving more than 84,000 patients daily across 40 states and Puerto Rico.

• ·Appointment follows search led by Nominating and Corporate Governance Committee with executive search firm and input from Khrom Capital.
• ·Goldman Sachs and J.P. Morgan serve as financial advisors; Kirkland & Ellis LLP as legal advisor.
• ·Mr. Cancelmi's 30+ years experience includes 11 years as Tenet CFO, overseeing acquisitions like USPI and hospital divestitures.
• ·Forward-looking risks include Medicaid changes from One Big Beautiful Bill Act (OBBBA) enacted July 4, 2025.

12-03-2026

Analog Devices, Inc. held its 2026 Annual Meeting of Shareholders on March 11, 2026, resulting in the election of all ten director nominees with strong shareholder support (ranging from approximately 93% to 99% votes for). Key management proposals passed overwhelmingly, including advisory approval of named executive officer compensation (90% for), ratification of Ernst & Young LLP as auditors for fiscal year ending October 31, 2026, and approval of the Amended and Restated 2020 Equity Incentive Plan (95% for). However, the non-binding shareholder proposal on special meeting rights was rejected, receiving only 38% support.

• ·Proxy statement filed with SEC on January 23, 2026; Plan adopted by Board on December 10, 2025
• ·Broker non-votes: 30,319,338 shares across relevant proposals

12-03-2026

Keurig Dr Pepper Inc. announced the pricing of private offerings for $2.55B in USD notes and €3.0B in Euro notes, consisting of multiple tranches with maturities from 2028 to 2056 and interest rates from 3.495% to 6.625%, to fund the JDE Peet’s Acquisition and related expenses. The notes are issued by Maple Parent Holdings Corp., initially guaranteed by the Company, with expected closing on March 26, 2026, subject to customary conditions. The filing highlights forward-looking risks including completion uncertainties, significant debt incurrence, integration challenges, potential credit downgrades, and share price impacts.

• ·Notes offered under Rule 144A and Regulation S, unregistered under Securities Act
• ·Guarantees terminate upon Separation; JDE Peet’s expected to guarantee post-acquisition
• ·Net proceeds to fund JDE Peet’s Acquisition, related fees, and expenses alongside other financing

12-03-2026

Artificial Intelligence Technology Solutions Inc. completed a 100-for-1 reverse stock split processed by FINRA on March 12, 2026, after which its Board of Directors unanimously voted not to proceed with a proposed Authorized Share Increase of 3.8B common shares filed via Definitive Information Statement on March 2, 2026. The authorized capitalization remains unchanged at 27.52B total shares, including 27.5B common shares and 20M preferred shares. No other material changes or performance metrics were reported.

• ·Reverse Stock Split ratio of 100 for 1 processed by FINRA on March 12, 2026

12-03-2026

Community Healthcare Trust Incorporated (CHCT) filed a Definitive Additional Proxy Material (DEFA14A) on March 12, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. This is soliciting material under §240.14a-12, filed by the registrant with no fee required. No substantive financial or operational details are provided in the filing header.

12-03-2026

Charter Communications, Inc. filed a DEFA14A Definitive Additional Materials proxy statement on March 12, 2026. The filing includes company details such as its address at 400 Washington Blvd., Stamford, CT, fiscal year end of December 31, and a prior name change on July 23, 1999. The provided content primarily consists of header information and encoded image data (e.g., ny20062718x2_nc01.jpg), with no discernible substantive proxy voting items, financial metrics, or period-over-period comparisons.

• ·Company EIN: 841496755
• ·Business phone: 203-905-7801
• ·SEC file number: 001-33664
• ·Standard Industrial Classification: Cable & Other Pay Television Services [4841]

12-03-2026

Liquidmetal Technologies reported total revenue of $784K for the year ended December 31, 2025, down 8.8% YoY from $860K in 2024, with products revenue declining 8.0% to $775K and licensing/royalties dropping 50.0% to $9K. Gross profit rose 6.0% to $230K with margins improving to 29.3% from 25.2%, but operating expenses increased 12.5% to $3.972M driven by 12.7% higher SG&A, leading to a wider operating loss of $3.742M (up 12.9%) and net loss of $2.342M (up 55.0% YoY). Other income fell 22.3% to $1.4M despite lease income surging 80.6% to $641K.

• ·No impairment charges recorded for long-lived assets in 2025 or 2024.
• ·No other-than-temporary impairment losses on debt securities in 2025 or 2024.
• ·Manufacture Supply Agreement with Dongguan Yihao dated January 12, 2022.
• ·Liquidmetal Golf License Agreement with Amorphous Technologies Japan dated January 13, 2022.
• ·Industrial/Commercial Multi-Tenant Lease dated March 26, 2025 with MatterHackers, Inc.
• ·Change of Control Agreement dated March 12, 2024 with Tony Chung and Isaac Bresnick.

12-03-2026

Supplemental proxy materials for the proposed reorganization of abrdn National Municipal Income Fund (VFL) into MFS Municipal Income Trust (MFM), which broadens VFL's investment mandate by removing the 20% limit on High Yield municipal bonds, allowing for 30-50% allocation compared to VFL's current 19% High Yield exposure versus MFM's 40%. The change aims to enhance income, support higher distributions, improve diversification, and achieve better risk-adjusted returns through access to a larger universe of higher-yielding bonds. While presenting modest increase in credit risk, management highlights benefits like lower expenses, larger fund size, and stronger long-term performance.

• ·VFL credit quality (12/31/25): AAA 2%, AA 45%, A 15%, BBB 21%, BB 2%, B 2%, CCC and below 1%, Not Rated 14%
• ·MFM credit quality (12/31/25): AAA 1%, AA 16%, A 23%, BBB 21%, BB 11%, B 3%, CCC and below 1%, Not Rated 25%
• ·Aberdeen's track record shows 0 defaults from 2017-2025 in Muni Suite compared to Bloomberg Muni Universe

12-03-2026

Lyell Immunopharma reported a reduced net loss of $274.4M for 2025 versus $343.0M in 2024, with operating expenses declining 25% to $269.4M driven by lower R&D ($158.7M, -7.5% YoY), G&A, IPR&D, and impairments. However, revenue fell sharply 41% YoY to $36K from $61K, cash and equivalents dropped to $60.2M from $105.6M, and total assets decreased to $340.1M from $490.9M amid ongoing cash burn.

• ·Net cash used in operating activities improved to $150.0M in 2025 from $162.4M in 2024.
• ·Proceeds from PIPE financing: $57.8M in 2025.
• ·Stock-based compensation expense: $41.8M in 2025, up from $33.1M in 2024.
• ·Acquired IPR&D expense: $66.3M in 2025, down from $87.2M in 2024.
• ·Impairment of long-lived assets: $1.4M in 2025, sharply down from $51.3M in 2024.

12-03-2026

Metallus Inc.'s DEF 14A proxy statement for the April 30, 2026 virtual annual meeting seeks shareholder approval for electing three independent directors (Nicholas J. Chirekos, Randall H. Edwards, Randall A. Wotring), ratifying Ernst & Young LLP as auditor for FY 2026, and advisory approval of NEO compensation. 2025 performance showed a full-year net loss of $1.2M due in part to a $6.6M benefit plan remeasurement loss (improved from $10.3M in 2024 and $40.6M in 2023), but adjusted EBITDA reached $75.6M with $13.1M in share repurchases, $157M cash, and $389M total liquidity as of December 31, 2025. The company highlighted sustainability progress including zero serious injuries, ISO 14001 certifications, and 930 thousand tons of recycled scrap melted, while pursuing 2030 environmental reduction goals.

• ·Annual meeting record date: February 27, 2026.
• ·Directors independent with committee roles: Chirekos (Audit), Edwards (Compensation, Nominating & Corporate Governance), Wotring (Compensation, Nominating & Corporate Governance).
• ·ISO 14001 certifications renewed for all domestic facilities in 2025.
• ·GHG emissions less than half global industry average.
• ·Plans to submit science-based GHG target for validation in 2026 per GSCC Steel Climate Standard.

12-03-2026

Saga Communications reported Q4 2025 net revenue of $26.5M, down 9.3% YoY from $29.2M, with digital revenue up 25.8% to $4.3M but station operating income down 38.7% to $3.6M, leading to an operating loss of $9.5M versus $1.0M income prior year due to a $20.4M impairment charge and resulting net loss of $6.9M. For FY2025, net revenue declined 5.1% to $107.1M from $112.9M, station operating expenses remained flat at $91.8M, station operating income fell 27.3% to $15.3M, and net loss was $7.9M versus $3.5M income, further impacted by the impairment and $2.2M music licensing settlement. While political revenue was low in this non-election year and core revenue ex-political dropped 4.7% in Q4, positives included a $11.6M gain from tower sales, $31.8M cash position, quarterly dividends of $0.25/share, and $2.5M share repurchases.

• ·Q4 2025 capital expenditures $0.4M vs $0.6M prior year.
• ·FY2025 capital expenditures $3.0M vs $3.8M prior year.
• ·Cash and short-term investments $31.5M as of March 9, 2026.
• ·2026 capex guidance $3.5M to $4.5M.
• ·Tower sale closed October 17, 2025; ~$0.4M escrow pending Q2 2026.
• ·Quarterly dividend $0.25/share declared Feb 12, 2026, record Feb 26, payable March 20, 2026.
• ·Total dividends since 2012 over $143M.
• ·No goodwill remains post-impairment.
• ·Q4 political revenue $0.254M vs $2.0M prior; FY $0.65M vs $3.3M.

12-03-2026

This DEFR14A is Amendment No. 1 to the proxy statement for the 2026 Annual Shareholder Meetings of four Putnam closed-end funds, including Putnam Municipal Opportunities Trust, amending proxy cards to correctly identify proposals without changing the substance of fixing Trustees at 8 or electing nominees. Each fund currently has 8 Trustees, with the Board recommending shareholders fix the number at 8 (flat from current) and elect the slate of nominees, including 7 Independent Trustees. Meetings are set for April 17, 2026; Trustees unanimously recommend FOR both proposals.

• ·Record Date: February 6, 2026
• ·Annual Meetings: April 17, 2026 at 11:00 a.m. ET, One Madison Avenue, New York, NY 10010
• ·Proxy materials mailed beginning March 10, 2026
• ·Putnam Managed Municipal Income Trust and Putnam Municipal Opportunities Trust have outstanding preferred shares; preferred holders vote separately to elect two Trustees (nominees: Robert D. Agdern and Peter Mason)
• ·All nominees currently serve as Trustees; Ms. Trust also serves 118 other funds

12-03-2026

Adobe reported record Q1 FY2026 revenue of $6.40B, up 12% YoY, with subscription revenue growing 13% to $6.20B, record operating cash flow of $2.96B, and AI-first ARR more than tripling YoY; Business Professionals & Consumers segment rose 16% to $1.78B while Creative & Marketing Professionals increased 12% to $4.39B. However, CEO Shantanu Narayen announced plans to transition after a successor is appointed, with Frank Calderoni appointed to lead the search committee. Q2 FY2026 revenue guidance is $6.43B-$6.48B, with FY2026 targets reaffirmed excluding pending Semrush acquisition.

• ·GAAP operating income $2.42B (up from $2.16B YoY); non-GAAP $3.04B.
• ·Q2 FY2026 GAAP EPS guidance $4.35-$4.40; non-GAAP $5.80-$5.85.
• ·Cash and equivalents $6.33B as of Feb 27, 2026 (up from $5.43B prior quarter).
• ·Share repurchases $2.48B in Q1 FY2026.